nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.222	0.286	CbGbCtD
Iloperidone—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.222	0.286	CbGbCtD
Iloperidone—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.166	0.214	CbGbCtD
Iloperidone—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.102	0.131	CbGbCtD
Iloperidone—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0649	0.0835	CbGbCtD
Iloperidone—HTR2A—arteriole—focal segmental glomerulosclerosis	0.0165	0.25	CbGeAlD
Iloperidone—Eye swelling—Cyclosporine—focal segmental glomerulosclerosis	0.00867	0.0856	CcSEcCtD
Iloperidone—HTR7—endothelium—focal segmental glomerulosclerosis	0.00542	0.0823	CbGeAlD
Iloperidone—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00462	0.07	CbGeAlD
Iloperidone—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00395	0.0599	CbGeAlD
Iloperidone—HTR2A—endothelium—focal segmental glomerulosclerosis	0.00338	0.0513	CbGeAlD
Iloperidone—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.032	CcSEcCtD
Iloperidone—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.0318	CcSEcCtD
Iloperidone—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.0311	CcSEcCtD
Iloperidone—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.0293	CcSEcCtD
Iloperidone—SIGMAR1—nephron tubule—focal segmental glomerulosclerosis	0.00291	0.0441	CbGeAlD
Iloperidone—HTR1D—kidney—focal segmental glomerulosclerosis	0.00274	0.0416	CbGeAlD
Iloperidone—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00273	0.0269	CcSEcCtD
Iloperidone—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.0265	CcSEcCtD
Iloperidone—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.025	CcSEcCtD
Iloperidone—SIGMAR1—cortex of kidney—focal segmental glomerulosclerosis	0.00249	0.0377	CbGeAlD
Iloperidone—ADRA2C—nephron tubule—focal segmental glomerulosclerosis	0.00228	0.0346	CbGeAlD
Iloperidone—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.0218	CcSEcCtD
Iloperidone—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00218	0.0216	CcSEcCtD
Iloperidone—HTR7—kidney—focal segmental glomerulosclerosis	0.00218	0.0331	CbGeAlD
Iloperidone—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.0208	CcSEcCtD
Iloperidone—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.0207	CcSEcCtD
Iloperidone—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.0201	CcSEcCtD
Iloperidone—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.0199	CcSEcCtD
Iloperidone—ADRA2C—kidney—focal segmental glomerulosclerosis	0.00201	0.0304	CbGeAlD
Iloperidone—ADRA2C—cortex of kidney—focal segmental glomerulosclerosis	0.00195	0.0296	CbGeAlD
Iloperidone—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.0192	CcSEcCtD
Iloperidone—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.00191	0.029	CbGeAlD
Iloperidone—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.0183	CcSEcCtD
Iloperidone—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.0179	CcSEcCtD
Iloperidone—CYP2E1—nephron tubule—focal segmental glomerulosclerosis	0.00178	0.027	CbGeAlD
Iloperidone—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.0168	CcSEcCtD
Iloperidone—CYP3A5—kidney—focal segmental glomerulosclerosis	0.00168	0.0255	CbGeAlD
Iloperidone—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.0164	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.0163	CcSEcCtD
Iloperidone—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.0162	CcSEcCtD
Iloperidone—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.00164	0.0248	CbGeAlD
Iloperidone—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.0159	CcSEcCtD
Iloperidone—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0158	CcSEcCtD
Iloperidone—CYP2E1—kidney—focal segmental glomerulosclerosis	0.00157	0.0238	CbGeAlD
Iloperidone—ADRA2A—cortex of kidney—focal segmental glomerulosclerosis	0.00156	0.0237	CbGeAlD
Iloperidone—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.0152	CcSEcCtD
Iloperidone—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.0152	CcSEcCtD
Iloperidone—CYP2E1—cortex of kidney—focal segmental glomerulosclerosis	0.00153	0.0231	CbGeAlD
Iloperidone—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.0148	CcSEcCtD
Iloperidone—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.0147	CcSEcCtD
Iloperidone—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.0138	CcSEcCtD
Iloperidone—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.0138	CcSEcCtD
Iloperidone—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.0137	CcSEcCtD
Iloperidone—HTR2A—kidney—focal segmental glomerulosclerosis	0.00136	0.0206	CbGeAlD
Iloperidone—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.0131	CcSEcCtD
Iloperidone—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.0127	CcSEcCtD
Iloperidone—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0126	CcSEcCtD
Iloperidone—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.0125	CcSEcCtD
Iloperidone—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00126	0.0191	CbGeAlD
Iloperidone—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.0123	CcSEcCtD
Iloperidone—CYP2D6—kidney—focal segmental glomerulosclerosis	0.00124	0.0188	CbGeAlD
Iloperidone—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.0122	CcSEcCtD
Iloperidone—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0117	CcSEcCtD
Iloperidone—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.0115	CcSEcCtD
Iloperidone—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.0114	CcSEcCtD
Iloperidone—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0113	CcSEcCtD
Iloperidone—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0112	CcSEcCtD
Iloperidone—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.011	CcSEcCtD
Iloperidone—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.0109	CcSEcCtD
Iloperidone—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.0104	CcSEcCtD
Iloperidone—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.0104	CcSEcCtD
Iloperidone—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0102	CcSEcCtD
Iloperidone—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.01	CcSEcCtD
Iloperidone—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00996	CcSEcCtD
Iloperidone—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.00989	CcSEcCtD
Iloperidone—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000989	0.00976	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000919	0.00907	CcSEcCtD
Iloperidone—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000905	0.00894	CcSEcCtD
Iloperidone—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000899	0.00888	CcSEcCtD
Iloperidone—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000896	0.00885	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000871	0.00859	CcSEcCtD
Iloperidone—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000869	0.00858	CcSEcCtD
Iloperidone—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000831	0.0082	CcSEcCtD
Iloperidone—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000797	0.00787	CcSEcCtD
Iloperidone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000723	0.00714	CcSEcCtD
Iloperidone—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00069	0.00681	CcSEcCtD
Iloperidone—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000667	0.00658	CcSEcCtD
Iloperidone—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000636	0.00628	CcSEcCtD
Iloperidone—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000635	0.00627	CcSEcCtD
Iloperidone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000599	0.00591	CcSEcCtD
Iloperidone—ADRA2A—Hemostasis—NOS2—focal segmental glomerulosclerosis	4e-05	0.000716	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.99e-05	0.000714	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.97e-05	0.00071	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.97e-05	0.000709	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.94e-05	0.000705	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	3.94e-05	0.000704	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.93e-05	0.000703	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.92e-05	0.000701	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	3.91e-05	0.000699	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.86e-05	0.00069	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.85e-05	0.000688	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.84e-05	0.000686	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	3.8e-05	0.00068	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.8e-05	0.000679	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	3.76e-05	0.000672	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.73e-05	0.000667	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.73e-05	0.000667	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.72e-05	0.000666	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.72e-05	0.000665	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—CTGF—focal segmental glomerulosclerosis	3.69e-05	0.00066	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.67e-05	0.000657	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.67e-05	0.000656	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.66e-05	0.000655	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.63e-05	0.000649	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.63e-05	0.000649	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.6e-05	0.000644	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.59e-05	0.000643	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.58e-05	0.000639	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.53e-05	0.00063	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.51e-05	0.000629	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.51e-05	0.000627	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.5e-05	0.000626	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.5e-05	0.000625	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.49e-05	0.000625	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.48e-05	0.000622	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.47e-05	0.000621	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.42e-05	0.000611	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.41e-05	0.00061	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	3.4e-05	0.000609	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.4e-05	0.000608	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.4e-05	0.000608	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.39e-05	0.000606	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.38e-05	0.000605	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.37e-05	0.000603	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	3.37e-05	0.000603	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	3.36e-05	0.000602	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.34e-05	0.000597	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.33e-05	0.000596	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.32e-05	0.000595	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.26e-05	0.000583	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.2e-05	0.000573	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.18e-05	0.00057	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.13e-05	0.000559	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.13e-05	0.000559	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	3.12e-05	0.000558	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.1e-05	0.000554	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.1e-05	0.000554	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.09e-05	0.000552	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.08e-05	0.000551	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.08e-05	0.00055	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.07e-05	0.00055	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.07e-05	0.000549	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.05e-05	0.000546	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.05e-05	0.000545	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.04e-05	0.000543	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.04e-05	0.000543	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.03e-05	0.000542	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.03e-05	0.000542	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.02e-05	0.00054	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.01e-05	0.000539	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	3e-05	0.000536	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.99e-05	0.000534	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.98e-05	0.000533	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.98e-05	0.000533	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.97e-05	0.000532	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.96e-05	0.00053	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.96e-05	0.000529	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.94e-05	0.000526	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.94e-05	0.000526	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.92e-05	0.000523	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.86e-05	0.000511	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.84e-05	0.000508	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.83e-05	0.000506	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.83e-05	0.000505	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.81e-05	0.000503	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.81e-05	0.000502	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.77e-05	0.000496	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.77e-05	0.000495	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.76e-05	0.000494	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.76e-05	0.000494	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.76e-05	0.000494	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.75e-05	0.000492	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	2.75e-05	0.000491	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.75e-05	0.000491	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.71e-05	0.000484	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.7e-05	0.000484	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.69e-05	0.000481	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.67e-05	0.000478	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.65e-05	0.000474	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	2.63e-05	0.000471	CbGpPWpGaD
Iloperidone—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.62e-05	0.000469	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.61e-05	0.000468	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.6e-05	0.000465	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.58e-05	0.000461	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.58e-05	0.000461	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.57e-05	0.00046	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	2.56e-05	0.000458	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.55e-05	0.000457	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.55e-05	0.000456	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.54e-05	0.000454	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.54e-05	0.000454	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.54e-05	0.000454	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.54e-05	0.000453	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.53e-05	0.000453	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.53e-05	0.000453	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.52e-05	0.00045	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.49e-05	0.000445	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.44e-05	0.000437	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.43e-05	0.000435	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.4e-05	0.00043	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.36e-05	0.000422	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.36e-05	0.000422	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.36e-05	0.000422	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.34e-05	0.000419	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.32e-05	0.000415	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.32e-05	0.000414	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.31e-05	0.000413	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.28e-05	0.000407	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.27e-05	0.000407	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.27e-05	0.000405	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.26e-05	0.000404	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	2.25e-05	0.000403	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	2.22e-05	0.000397	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.21e-05	0.000395	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.2e-05	0.000394	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.2e-05	0.000394	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.2e-05	0.000393	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.2e-05	0.000393	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	2.19e-05	0.000391	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.17e-05	0.000388	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.14e-05	0.000383	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.13e-05	0.000381	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.11e-05	0.000378	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.09e-05	0.000374	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.08e-05	0.000373	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	2.08e-05	0.000372	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.03e-05	0.000363	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.03e-05	0.000362	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2e-05	0.000359	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2e-05	0.000358	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.97e-05	0.000352	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.96e-05	0.000351	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.96e-05	0.000351	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.96e-05	0.000351	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	1.95e-05	0.000349	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.95e-05	0.000349	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.94e-05	0.000347	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.93e-05	0.000345	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.91e-05	0.000342	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—LPL—focal segmental glomerulosclerosis	1.91e-05	0.000341	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.91e-05	0.000341	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	1.9e-05	0.000341	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.89e-05	0.000338	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.88e-05	0.000336	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.88e-05	0.000336	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.88e-05	0.000336	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.87e-05	0.000334	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.84e-05	0.000329	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.83e-05	0.000327	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.81e-05	0.000323	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.8e-05	0.000323	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.8e-05	0.000322	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.79e-05	0.00032	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	1.78e-05	0.000318	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.77e-05	0.000317	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.75e-05	0.000313	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.74e-05	0.000311	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.74e-05	0.000311	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	1.73e-05	0.000309	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.69e-05	0.000302	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.69e-05	0.000302	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.69e-05	0.000302	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	1.68e-05	0.0003	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.67e-05	0.000298	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.66e-05	0.000297	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.65e-05	0.000296	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.65e-05	0.000294	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.63e-05	0.000292	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—AGT—focal segmental glomerulosclerosis	1.63e-05	0.000292	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.63e-05	0.000292	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	1.63e-05	0.000291	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.6e-05	0.000286	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.53e-05	0.000274	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.52e-05	0.000273	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.51e-05	0.00027	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.51e-05	0.000269	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.5e-05	0.000269	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.5e-05	0.000269	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.49e-05	0.000267	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.49e-05	0.000266	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.48e-05	0.000264	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.45e-05	0.00026	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.45e-05	0.000259	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.45e-05	0.000259	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.44e-05	0.000257	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.41e-05	0.000252	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.37e-05	0.000246	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	1.36e-05	0.000244	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	1.35e-05	0.000242	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.3e-05	0.000232	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.28e-05	0.000229	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.28e-05	0.000228	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.28e-05	0.000228	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.26e-05	0.000225	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.25e-05	0.000224	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—ALB—focal segmental glomerulosclerosis	1.25e-05	0.000224	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	1.25e-05	0.000224	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.24e-05	0.000222	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.24e-05	0.000222	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.23e-05	0.00022	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.23e-05	0.00022	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.19e-05	0.000212	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.18e-05	0.00021	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	1.16e-05	0.000207	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	1.15e-05	0.000205	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.14e-05	0.000204	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.11e-05	0.000199	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.11e-05	0.000198	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.08e-05	0.000193	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.07e-05	0.000191	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.05e-05	0.000188	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	9.81e-06	0.000175	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.78e-06	0.000175	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.62e-06	0.000172	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.6e-06	0.000172	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.42e-06	0.000168	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.18e-06	0.000164	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.13e-06	0.000163	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	8.89e-06	0.000159	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.88e-06	0.000159	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	8.85e-06	0.000158	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.75e-06	0.000157	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.06e-06	0.000144	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.93e-06	0.000142	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.91e-06	0.000142	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.76e-06	0.000139	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	7.57e-06	0.000135	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	7.53e-06	0.000135	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.21e-06	0.000129	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	5.81e-06	0.000104	CbGpPWpGaD
